Who are Corisma's investors?

Corisma's investors include Connecticut Innovations.

How much funding has Corisma raised?

Corisma has disclosed $5.2M raised across 1 round.

Where is Corisma headquartered?

Corisma is headquartered in Hamden, US.

Corisma

Hamden, US · Founded 2018 · 1 known investors

Find your way into Corisma

Paths you didn't know you had: your email and LinkedIn already hold routes to the Corisma team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Corisma develops a fully implanted transcatheter mechanical circulatory support system for advanced heart failure patients, designed to bridge acute and chronic care with improved quality of life. The device eliminates the driveline and uses wireless, catheter-based technology to replace current standard-of-care treatment options.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

R. William Vogel Chief Executive OfficerR. William Vogel holds an MBA from Harvard Business School and a BS in Mechanical Engineering from Yale University, and brings over 25 years of healthcare industry experience spanning medical devices, healthcare services, and IT, including prior executive roles at Royal Philips and leadership of multiple healthcare companies across corporate, private equity, and start-up sectors.

Yuhang ZhaoNamed on SEC filing

Michael TheranNamed on SEC filing

Board

Kaushik MandalChairman

Investors · 1

Connecticut Innovationslisted by Connecticut InnovationsNew Haven · $500K – $2M

How we know: Connecticut Innovations's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$5.2M disclosed across 1 round · 2021

▶$5.2MraisedAug 2021 · 24 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Yuhang ZhaoDirector
Michael TheranExecutive Officer, Director

Offering amount: $14M
Amount sold: $5.2M
First sale: Aug 2021
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Corisma do?: Corisma develops a fully implanted transcatheter mechanical circulatory support system for advanced heart failure patients, designed to bridge acute and chronic care with improved quality of life. The device eliminates the driveline and uses wireless, catheter-based technology to replace current standard-of-care treatment options.
Who are Corisma's investors?: Corisma's investors include Connecticut Innovations.
How much funding has Corisma raised?: Corisma has disclosed $5.2M raised across 1 round.
Where is Corisma headquartered?: Corisma is headquartered in Hamden, US.